NCT07485218

Brief Summary

With our study, the investigators aim to assess the impact of the fatigue experienced during daily life activities (tiredness) and whether there is a relationship with muscle fatigue during an exercise task. The results of this study may be used to improve the assessment of fatigue in older adults and enhance clinical management.

  1. 1.General information An increase in fatigue is considered one of the main causes of reduced quality of life in older adults and in people suffering from chronic diseases. However, the investigators still know little about the mechanisms underlying fatigue in older adults, mainly because most of the available tools were developed to assess this symptom in younger populations with specific diseases, without proper adjustments for physical activity or age.
  2. 2.Study procedure
  3. 3.First, participants will be instructed on how to perform the surrogate walking test, which evaluates leg muscle fatigue.
  4. 4.After a 5-minute rest, participants will be asked to perform the handgrip test with participants' right hand (see Figure 3). The maximal handgrip test will be performed while seated, with participants' forearm resting on a table. The test will be repeated several times until participants are instructed to stop.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Dec 2024

Typical duration for all trials

Geographic Reach
2 countries

5 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Dec 2024Mar 2027

Study Start

First participant enrolled

December 17, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 10, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 20, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

March 10, 2026

Last Update Submit

March 23, 2026

Conditions

Keywords

AgedParkinson DiseaseAging in PlaceNursing Home ResidentsMuscle Strength DynamometerFatigue

Outcome Measures

Primary Outcomes (5)

  • PFS_mental subscale

    The score of the Pittsburgh Fatigability Scale (PFS) mental subscale. Mental Fatigability Score: Calculated by summing the mental fatigue rating for each activity (a-j). Score range (0-50) with higher score=greater mental fatigability.

    Baseline

  • PFS_physical subscale

    The score of the physical subscale. Physical Fatigability Score: Calculated by summing the physical fatigue rating for each activity (a-j). Score range (0-50) with higher score=greater physical fatigability.

    Baseline

  • FSS

    the total score of the Fatigue Severity Scale (FSS). Each question is graded on a 7-point Likert scale ranging from 1 ("completely disagree") to 7 ("completely agree"). Score range (9-63) with higher score=greater fatigue.

    Baseline

  • EMG variables

    variables extracted from the surface EMG signal will be used to measure the variations of performance fatigability

    Baseline

  • Torque

    Torque signal will be used to measure the intensity of performance fatigability

    Baseline

Study Arms (3)

Nursing homes OA

No intervention. Older adults living in a nursing home located in southern Switzerland and with an age greater than 80 years.

Community-dwelling OA

No intervention. Older adults living at their homes with an age comprised between 65 and 75 years.

PD OA

Older outpatients with early phases of Parkinson's Disease, with age greater than 65 years.

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Three cohorts: 1. Nursing homes OA 40 residents in a nursing home of southern Switzerland will be recruited. The study will not affect any treatment. The key inclusion criteria for the participants' eligibility will be age greater than 80 years, modified Barthel Index score ≥85 points \[Tofani et al., 2019\] and ADL index score ≤12 points \[Katz et al., 1963\]. 2. Community-dwelling OA 40 active community-dwelling older people will be recruited. The key inclusion criterion for the participants' eligibility is an age comprised between 65 and 75 years. 3. 40 older outpatients with early phases of PD will be recruited. People with PD fulfilling the key inclusion and the following criterium are eligible for this study (see above): • Primary parkinsonism stages I-III of clinical disability, according to Hoehn and Yahr \[1967\].

You may qualify if:

  • Age greater than 65 years.

You may not qualify if:

  • No understanding of the project language (Italian);
  • Moderate to severe dementia, with a Short Portable Mental Status Questionnaire (SPMSQ) score ≥1 \[Pfeiffer, 1975\] or Cognitive Performance Scale (CPS) ≥3 \[Morris et al., 1994\];
  • Psychiatric disorders and moderate neurodegenerative diseases;
  • Delirium;
  • Persistent infections;
  • Inability to follow the study procedures (due to psychological disorders or dementia);
  • Severe hearing problem;
  • Unable or refuse to perform the physical tests (maximal handgrip strength, leg extension);
  • Severe cardiovascular and lung diseases (acute infection, heart, or lung failure, unstable angina and myocardial infarction during the previous month);
  • Renal failure, hepatic dysfunction;
  • Recent major surgery;
  • Severe cardiovascular exacerbations (RR \> 240/120, HR above the age predicted maximum of 220-Age);
  • Participation in another study with investigational drug within the 30 days preceding and during the present study;
  • Drug treatments that may interfere with the fatigue level;
  • Lifestyle factors and / or persistent addictions (drug or alcohol abuse).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Neuroimaging Research Unit, Division of Neuroscience San Raffaele Scientific Institute, Vita - Salute San Raffaele University

Milan, MI, 20132, Italy

Location

Multistruttura Sezione Anziani

Bellinzona, Canton Ticino, 6500, Switzerland

Location

University of Applied Sciences and Arts of Southern Switzerland

Manno, Canton Ticino, 6928, Switzerland

Location

Fondazione Parco San Rocco

Morbio Inferiore, Canton Ticino, 6834, Switzerland

Location

Fondazione Opera Charitas

Sonvico, Canton Ticino, 6968, Switzerland

Location

Related Publications (7)

  • Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427-42. doi: 10.1212/wnl.17.5.427. No abstract available.

    PMID: 6067254BACKGROUND
  • KATZ S, FORD AB, MOSKOWITZ RW, JACKSON BA, JAFFE MW. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA. 1963 Sep 21;185:914-9. doi: 10.1001/jama.1963.03060120024016. No abstract available.

    PMID: 14044222BACKGROUND
  • Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, Lipsitz LA. MDS Cognitive Performance Scale. J Gerontol. 1994 Jul;49(4):M174-82. doi: 10.1093/geronj/49.4.m174.

    PMID: 8014392BACKGROUND
  • Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975 Oct;23(10):433-41. doi: 10.1111/j.1532-5415.1975.tb00927.x.

    PMID: 1159263BACKGROUND
  • Beretta-Piccoli M, Cescon C, Barbero M, Villiger M, Clijsen R, Kool J, Kesselring J, Bansi J. Upper and lower limb performance fatigability in people with multiple sclerosis investigated through surface electromyography: a pilot study. Physiol Meas. 2020 Mar 6;41(2):025002. doi: 10.1088/1361-6579/ab6f54.

    PMID: 31972554BACKGROUND
  • Vercelli S, Zampogna E, Negrini F, Pietraroia C, D'Antona G, Papa S, Soldini E, Barbero M, Glynn NW, Beretta-Piccoli M. Cross-cultural translation, validation, and responsiveness of the Pittsburgh Fatigability Scale - Italian version (PFS-I) in a mixed-sample of older adults. BMC Geriatr. 2024 Dec 19;24(1):1016. doi: 10.1186/s12877-024-05603-z.

    PMID: 39702098BACKGROUND
  • Siciliano M, Chiorri C, De Micco R, Russo A, Tedeschi G, Trojano L, Tessitore A. Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach. Parkinsonism Relat Disord. 2019 Aug;65:105-110. doi: 10.1016/j.parkreldis.2019.05.028. Epub 2019 May 22.

    PMID: 31147224BACKGROUND

Related Links

MeSH Terms

Conditions

Parkinson DiseaseFatigue

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior researcher and lecturer

Study Record Dates

First Submitted

March 10, 2026

First Posted

March 20, 2026

Study Start

December 17, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

March 27, 2026

Record last verified: 2026-03

Locations